Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapy.

Saved in:
Bibliographic Details
Title: Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapy.
Authors: Chernyavska M; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Hartmann KP; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Jansen JHM; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Baumann N; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany., Kolibius J; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Brücher D; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Kristoforus T; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Peters RHW; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Huijs L; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Laarveld D; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Weiss F; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Burger R; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany., Lustig M; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany., Gimenez de Assis N; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Schmid M; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Leusen JHW; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Valerius T; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany., Plückthun A; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Verdurmen WPR; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands. Wouter.Verdurmen@radboudumc.nl.
Source: EMBO molecular medicine [EMBO Mol Med] 2026 Jul 07. Date of Electronic Publication: 2026 Jul 07.
Publication Type: Journal Article
Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1757-4684
DOI:10.1038/s44321-026-00477-7